<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
</head>
<body><p style="text-align:justify;"><strong>Bronchial Asthma</strong></p><p style="text-align:justify;"><span >Asthma is a chronic inflammatory disease of the bronchial airways, which manifests as recurrent episodes of wheeze, cough, chest tightness and shortness of breath, which is usually reversible with treatment. It is characterised by increased sensitivity to many environmental agents. Asthma is variable and may be associated with seasons like the rainy season or harmattan. Bronchial asthma occurs at all ages but peaks in childhood. It is classified as an allergic disease, and may be associated with a personal or family history of allergic rhinitis (hay fever), eczema or allergic conjunctivitis.</span></p><p style="text-align:justify;"><span >Complications of asthma include pneumomediastinum, pneumothorax, subcutaneous emphysema and pneumonia.</span></p><h3> CAUSES</h3><ul><li> Allergens e.g. house dust mite, cockroach droppings, grass, pollen and animal hair</li><li> Environmental factors e.g. air pollution, climatic changes, strong scents and smoke (including cigarette smoke and car fumes)</li><li> Viral infections</li><li> Exercise</li><li> Emotions and hyperventilation</li><li> Drugs e.g. aspirin, NSAIDS and beta-blockers such as propranolol</li><li> Occupational exposure to industrial chemicals, dust and drug manufacturing</li></ul><h3>SYMPTOMS</h3><ul><li>Episodic breathlessness</li><li>Tightness of the chest</li><li>Cough - often nocturnal</li><li>Wheeze</li><li>Nocturnal symptoms. Any of the above symptoms waking up the patient at night</li></ul><h3>SIGNS</h3><ul><li>Tachypnoea (fast breathing)</li><li>Use of accessory muscles of respiration; neck and/or abdominal muscles</li><li>Rhonchi/wheeze</li><li><strong>Signs of severe attack:</strong><ul><li>Inability to complete full sentences in one breath</li><li>Rapid pulse &gt; 110/minute in adults and adolescents or &gt;130/ minute in children 2-5 years</li><li>Rapid respiration &gt; 30/minute in adults and adolescents or or &gt; 50/minute in children 2-5 years</li><li>Peak Expiratory Flow Rate (PEFR) is reduced &lt; 50% of expected (for age, sex and height)</li></ul></li><li><strong>Signs of a life-threatening attack are:</strong><ul><li>Cyanosis</li><li>Pulsus paradoxus</li><li>Silent chest on auscultation</li><li>Drowsiness or confusion</li><li>Exhaustion</li><li>Peak Expiratory Flow Rate (PEFR)less than 33 % of expected value</li><li>SpO2 less than 92% on room air</li></ul></li></ul><h3>INVESTIGATIONS</h3><ul><li>No investigation required in most cases</li><li>FBC, mildly high eosinophil count</li><li>Chest X-ray (only for the exclusion of other diagnoses or complications)</li><li style="text-align:justify;">Spirometry - reduction in FEV1 and FEV1/FVC ratio with reversibility demonstrated after bronchodilator use (a normal spirometry between attacks does not exclude asthma).</li><li style="text-align:justify;">Tests for atopy - skin prick test or specific IgE for common allergens</li><li style="text-align:justify;">Stool examination, exclude helminthiasis</li></ul><h3>TREATMENT</h3><p><strong>Treatment objectives</strong></p><ul><li>To relieve bronchospasm</li><li>To prevent complications and recurrence</li><li>To treat underlying inflammation or infection</li></ul><h3>Non-pharmacological treatment</h3><ul><li>Avoid known triggers/allergens, such as dust (dust mite) where possible</li><li>Avoid smoking</li><li>Education on asthma self management, device use and technique</li></ul><h3>Pharmacological treatment</h3><p><span ><strong>A. Acute Exacerbation of Asthma: Initial Management in the Community</strong></span></p><p><span ><strong>Evidence Rating: [C]</strong></span></p><ul><li>Salbutamol inhaler, using pressurized metered dose inhaler (pMDI) with a spacer</li></ul><p><strong><u>Adults</u> and <u>Children</u></strong></p><p>Give 1-2 puffs via a spacer and mask if needed (e.g. Volumatic <strong>Or</strong></p><p>Aerochamber, or large plastic mineral water bottle) with the patient taking 3-4 breaths after each puff.</p><p>Repeat after every 15-30 minutes maximum 10 doses.</p><p>If there is no improvement seek care at a health facility with a nebuliser.</p><p><span ><strong>B. Acute Moderate/Severe Exacerbation of Asthma: Initial Management in Hospital</strong></span></p><p><span ><strong> 1<sup>st</sup> Line Treatment Evidence Rating: [A]</strong></span></p><ul><li>Oxygen</li></ul><p>By nasal prongs 2-6 L/min</p><h3>Or</h3><p>Face mask4-8 L/min</p><p><strong>Or</strong></p><p style="margin-left:0in;">Non-rebreather mask 10-15 L/min</p><h3>And</h3><ul><li>Salbutamol, nebulised,</li></ul><p><strong><u>Adults</u></strong></p><p>2.5-5 mg repeated initially after 15-30 minutes, then every 2-4 hours until improved</p><p><strong><u>Children</u></strong></p><p>2.5-5 mg every 2-4 hours until improved</p><p><span ><strong>And</strong></span></p><ul><li>Ipratropium bromide, nebulised,</li></ul><p><strong><u>Adults</u></strong></p><p>500 microgram 4-6 hourly</p><p><strong><u>Children</u></strong></p><p>6-12 years; 250 microgram 4-6 hourly</p><p>1-5 years; 125 microgram 4-6 hourly (max. dose for children is 1 mg/24 hours)</p><p><span ><strong>And</strong></span></p><ul><li>Hydrocortisone, IV,</li></ul><p><strong><u>Adults</u></strong></p><p>200 mg stat. then 100 mg 6 hourly until clinical improvement</p><p><strong><u>Children</u></strong></p><p>12-18 years;  100 mg 6-8 hourly</p><p>1 month-12 years;  2-4 mg/kg 8 hourly</p><h3><strong>Then</strong></h3><p><span ><strong>C. Acute Moderate/Severe Exacerbation of Asthma: Maintenance Treatment in Hospital</strong></span></p><p> â€¢ Salbutamol, nebulised,</p><p><strong><u>Adults</u></strong></p><p>2.5-5 mg repeated every 6 hours until improved</p><p><strong><u>Children</u></strong></p><p>2.5-5 mg every 6 hours until improved</p><h3>And</h3><ul><li>Ipratropium bromide, nebulised,</li></ul><p><strong><u>Adults</u></strong></p><p>500 microgram 4-6 hourly</p><p><strong><u>Children</u></strong></p><p>6-12 years; 250 microgram 4-6 hourly</p><p>1-5 years; 125 microgram 4-6 hourly (max. dose for children 1 mg/24 hours)</p><h3>And</h3><ul><li style="text-align:justify;">Prednisolone, oral, initial dose given on admission and subsequently given as a morning dose. (Once on prednisolone, stop IV hydrocortisone after 24 hours)</li></ul><p><strong><u>Adults</u></strong></p><p>30-40 mg daily for 7 days until stable. Taper off dose over a period of 2 weeks if patient has been on long term steroids.</p><p><strong><u>Children</u></strong></p><p>1-2 mg/kg for 3-5 days</p><p><span ><strong>D. Acute Moderate/Severe Exacerbation of Asthma: Maintenance Treatment in Hospital(where patient is still distressed after 3-4 initial doses of nebulised salbutamol)</strong></span></p><ul><li style="text-align:justify;">Aminophylline, IV,</li></ul><p><strong><u>Adults</u></strong></p><p>250 mg slow injection over 20 minutes</p><p>Repeat after 30 minutes with a continuous infusion by perfusor, if necessary, at a rate not exceeding 0.5 mg/kg/hour over 24 hours</p><h3>Or</h3><ul><li>Aminophylline, IV infusion, 250 mg in 500 ml of 5% Dextrose or 0.9% Sodium Chloride, 6 hourly for 24 hours</li></ul><p><strong><u>Children</u></strong></p><p>5 mg/kg over 20 minutes as a slow infusion or by perfusor at 1mg/ kg/hour (max. 500 mg)</p><p><span ><strong>E. Chronic Asthma - Initial management</strong></span></p><p><span ><strong>Evidence Rating: [A]</strong></span></p><ul><li>Salbutamol, inhaled,</li></ul><p><strong><u>Adults</u> and children</strong></p><p>100 microgram, 2 puffs as often as needed</p><h3>And</h3><p><span >(If inhaled Salbutamol is needed more than once daily)</span></p><ul><li>Budesonide, inhaled,</li></ul><p><strong><u>Adults</u></strong></p><p>200 microgram (one puff 12 hourly)</p><p><strong><u>Children</u></strong></p><ul><li>10 years; 200 microgram (one puff 12 hourly)</li><li>&lt; 10 years; 100 microgram (one puff 12 hourly)</li></ul><h3>Or</h3><ul><li>Fluticasone, Inhaled - MDI,</li></ul><p><strong><u>Adults</u></strong></p><p>125-250 microgram (2 puffs 12 hourly)</p><p><strong><u>Children</u></strong></p><p>50 microgram (2 puffs 12 hourly)</p><h3>Or</h3><ul><li>Beclometasone (Beclomethasone), inhaled,</li></ul><p><strong><u>Adults</u> and <u>Children</u></strong></p><p>100 microgram (2 puffs 12 hourly)</p><p><span ><strong>F. Chronic Asthma - Maintenance treatment</strong></span></p><ul><li>Salbutamol, inhaled,</li></ul><p><strong><u>Adults</u> and children</strong></p><p>100 microgram, 2 puffs as often as needed</p><h3>And</h3><ul><li>Fluticasone/Salmeterol, inhaled,</li></ul><p><strong><u>Adults</u> and children over 5 years</strong></p><p>100/50-250/50 microgram; 1 puff 12 hourly</p><h3>Or</h3><ul><li>Budesonide/Formoterol , inhaled,</li></ul><p><strong><u>Adults</u></strong></p><p>160/4.5 microgram (1-2 puffs 12 hourly)</p><p><strong><u>Children</u> over 5 years</strong></p><p>80/4.5 microgram (1-2 puffs 12 hourly)</p><h3>And</h3><ul><li>Montelukast, oral,</li></ul><p><strong><u>Adult</u></strong></p><p>10 mg daily</p><p><strong><u>Children</u></strong></p><p>4 or 5 mg granules daily</p><h3>And</h3><ul><li>Prednisolone, oral,</li></ul><p><strong><u>Adults</u></strong></p><p>30-40 mg daily and tail down slowly over 2-3 week period to a low maintenance daily dose of 5 mg daily.</p><p><strong><u>Children</u></strong></p><p>1 mg/kg tailed off by 5 mg every third day, reducing to 5-10 mg daily or alternate daily, lowest dose possible without provoking attacks</p><h3>REFERRAL CRITERIA</h3><p style="text-align:justify;"><span >In acute exacerbation, refer patients if not improving or rapidly deteriorating after initial management to a specialist.</span></p><p style="text-align:justify;"><span >All discharged clients should be followed up within one week and referred to a specialist clinic for continued care.</span></p><p style="text-align:justify;"><span >For chronic asthma refer patients with persistent symptoms to a specialist clinic in a regional or tertiary hospital, and patients who have recurrent acute exacerbations within a few days/ weeks of each other for specialist care and review of their treatment.</span></p><p style="text-align:justify;"><span >Also refer when a patient requires more than one course of oral prednisolone in 3 months.</span></p>
</body>
</html>
